Effects of B cell depletion on T cell allogeneic Immune responses: A strategy to reduce allogeneic sensitization

Transplant Immunology

Volumn 21, Issue 4, 2009, Pages 215-220

  Tsai, Meng Kun ^a,b   Chien, Hsiung Fei ^a,b   Tzeng, Mei Ching ^a,b   Lee, Po Huang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Allogeneic sensitization; B cell depletion; Memory T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN; GAMMA INTERFERON; HERMES ANTIGEN; L SELECTIN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CARDIAC GRAFT REJECTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT SURVIVAL; HEART GRAFT; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SPLEEN CELL; SURVIVAL TIME; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CELL PROLIFERATION; GRAFT REJECTION; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSION; INTERFERON-GAMMA; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 68949163772     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.06.006     Document Type: Article

References (30)

1. Genberg H., Kumlien G., Wennberg L., Gerg U., and Tyden G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 85 (2008) 1745-1754
2. Faguer S., Kamar N., Guilbeaud-Grugier C., et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 83 (2007) 1277-1280
3. Terasaki P.I., and Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 4 (2004) 438-443
4. Billing H., Reiger S., Ovens J., et al. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplantation recipients. Transplantation 86 (2008) 1214-1221
5. Noorchashm H., Reed A.J., Rostami S.Y., et al. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol 177 (2006) 7715-7722
6. Silveira P.A., Johnson E., Chapman H.D., et al. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol 32 (2002) 3657-3666
7. Bouasziz J., Yanaba K., Venturi G.M., et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. PNAS 104 (2007) 20,878-20,883
8. Li Y., Chen F., Putt M., et al. B cell depletion with anti-CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice. J Immunol 181 (2008) 2961-2972
9. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189: 1639-1648. J Immunol. 1999; 163:3592-3596.
10. Chan O.T., Madaio M.P., and Shlomchik M.J. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 163 (1999) 3592-3596
11. Martin F., and Chan A.C. B cell immunobiology in disease: evolving concepts from the clinic. Ann Rev Immunol 24 (2006) 467-496
12. Epstein M.M., Di Rossa F., Jankovic D., Sher A., and Matzinger P. Successful T cell priming in B cell-deficient mice. J Exp Med 182 (1995) 915-922
13. Hasan M., Polic B., Bralic M., Jonjic S., and Rajewsky K. Incomplete block of B cell development and immunoglobulin production in mice carrying the muMT mutation in the BALB/c background. Eur J Immunol 32 (2002) 3463-3471
14. Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals. PNAS 93 (1996) 14,720-14,725
15. Topham D.J., Tripp R.A., Hamilton-Easton A.M., Sarawar S.R., and Doherty P.C. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in absence of B cells and Ig. J Immunol 157 (1996) 2947-2952
16. Tsai M.K., Ho H.N., Chien H.F., Ou-Yang P., Lee C.J., and Lee P.H. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis. Transplantation 77 (2004) 48-54
17. Haluszczak C., Akue A.D., Hamilton S.E., et al. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med 206 (2009) 435-448
18. Tsai M.K., Ho H.N., Chien H.F., et al. Multiple negative feedbacks on CD152 expression in allograft tolerance. Transplantation 79 (2005) 174-181
19. Macleod M.K.L., McKee A., Crawford F., White J., Kappler J., and Marrack P. CD4 memory T cells divide poorly in response to antigen because of their cytokine profile. PNAS 105 (2008) 14,521-14,526
20. Hu C., Daniel R., Du W., et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 117 (2007) 3857-3867
21. Menard L.C., Minns L.A., Darche S., et al. B cells amplify IFN-γ production by T cells via a TNF-α-mediated mechanism. J Immunol 179 (2007) 4857-4866
22. Nozaki T., Rosenblum Jm., Ishii D., Tanabe K., and Fairchild R.L. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice. J Immunol 181 (2008) 5257-5263
23. Homann D., Tishon A., Berger D.P., et al. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice. J Virol 72 (1998) 9208-9216
24. Saout C.L., Mennechet S., Taylor N., and Hernandez J. Memory-like CD8 and CD4+ T cells coerate to break eripheral tolerance under lymphopenic conditions. PNAS 105 (2008) 19,414-19,419
25. Bingaman A.W., and Farber D.L. Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant 4 (2004) 846-852
26. Lee P.C., Terasaki P.I., Takemoto S.K., et al. All chronic rejection failures of kidney transplant were preceded by the development of HLA antibodies. Transplantation 74 (2002) 1192-1194
27. Gupta M., Satyaraj E., Durdik J.M., Rath S., and Bal V. Differential regulation of T cells activation for primary versus secondary proliferative responses. J Immunol 158 (1997) 4113-4121
28. Trzonkowski P., Zilvetti M., Friend P., and Wood K.J. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Transplantation 82 (2006) 1342-1351
29. Bestard O., Nickel P Cruzado J.M., et al. Circulating alloreactive T cells correlated with graft function in longstanding renal transplant recipients. J Am Soc Nephrol 19 (2008) 1419-1429
30. Becker Y.T., Becker B.N., Pirsch J.D., and Sollinger H.W. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 4 (2004) 996-1001